Orthopedic Devices - EU-27

  • EU-27
  • Revenue in the Orthopedic Devices market in European Union (EU27) is projected to reach US$10.02bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.95%, resulting in a market volume of US$11.59bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$16,020.00m in 2024).

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in EU-27 is experiencing steady growth due to increasing customer preferences for advanced orthopedic technologies and the rising prevalence of orthopedic conditions.

Customer preferences:
Customers in the EU-27 region are increasingly demanding orthopedic devices that offer better functionality, durability, and improved patient outcomes. They are willing to invest in technologically advanced devices that provide faster recovery times, reduced pain, and improved mobility. Additionally, there is a growing preference for minimally invasive surgical procedures, driving the demand for orthopedic devices that support these techniques.

Trends in the market:
One of the key trends in the Orthopedic Devices market in EU-27 is the adoption of 3D printing technology. This technology allows for the production of patient-specific implants and prosthetics, resulting in better fit and improved patient satisfaction. The use of 3D printing also enables faster production and customization, reducing lead times and costs. Another trend is the increasing use of robotics in orthopedic surgeries, which enhances surgical precision and reduces the risk of human error. Robotic-assisted surgeries are becoming more common for joint replacements and spine surgeries, leading to improved patient outcomes.

Local special circumstances:
In certain EU-27 countries, such as Germany and France, there is a strong focus on research and development in the orthopedic field. These countries have well-established medical device industries and academic institutions that drive innovation and technological advancements. This creates a favorable environment for the growth of the Orthopedic Devices market. Additionally, the presence of a well-developed healthcare infrastructure and high healthcare expenditure in these countries further supports market growth.

Underlying macroeconomic factors:
The aging population in the EU-27 region is a significant macroeconomic factor driving the growth of the Orthopedic Devices market. With an increasing number of elderly individuals, the prevalence of orthopedic conditions such as osteoarthritis and osteoporosis is rising. This creates a higher demand for orthopedic devices, including joint replacements, spinal implants, and orthobiologics. Furthermore, the growing awareness about the importance of maintaining an active and healthy lifestyle is also contributing to the market growth, as individuals seek orthopedic solutions to address sports injuries and musculoskeletal conditions. In conclusion, the Orthopedic Devices market in EU-27 is witnessing steady growth due to customer preferences for advanced orthopedic technologies, the adoption of 3D printing and robotics, local special circumstances such as research and development focus, and underlying macroeconomic factors such as the aging population and increasing awareness about orthopedic solutions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)